Related Experiment Video
Updated: Aug 8, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Atherosclerosis and vascular calcification in chronic renal failure
V Campean1, D Neureiter, I Varga
1Department of Pathology, Med. II and Med. IV, University of Erlangen-Nurnberg, Erlangen, Germany.
Insights
Patients with chronic kidney disease face high cardiovascular risks, including increased heart attack rates and mortality. Non-traditional factors like inflammation and oxidative stress contribute significantly to these cardiac complications.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular complications are a leading cause of death in chronic kidney disease (CKD) and end-stage renal failure (ESRF) patients.
- Uremic patients exhibit a 20-fold higher risk of cardiovascular death compared to the general population, exceeding even that of diabetic patients.
- High rates of myocardial infarction and increased case fatality are observed in CKD patients, irrespective of diabetes status.
Purpose of the Study:
- To investigate the significant burden of cardiovascular complications in patients with kidney disease.
- To explore the roles of both traditional and non-traditional risk factors in the pathogenesis of cardiac issues in renal failure.
- To highlight the unique aspects of atherosclerosis and arteriosclerosis in the context of renal failure.
Main Methods:
- Review of autopsy and coronary angiography studies to assess coronary atheroma prevalence.
- Analysis of clinical and autopsy data on plaque formation and vascular calcification.
- Examination of the contribution of nonclassical risk factors like microinflammation, hyperphosphatemia, and oxidative stress.
Main Results:
- Coronary atheroma prevalence is approximately 30% in uremic patients.
- CKD patients show significantly higher myocardial infarction case fatality rates.
- Renal failure is associated with increased plaque formation and vascular calcification.
- Nonclassical risk factors (microinflammation, hyperphosphatemia, oxidative stress) play a crucial role.
Conclusions:
- Cardiovascular disease is a major, life-threatening issue in CKD and ESRF.
- Both coronary and non-coronary factors contribute to cardiac complications in renal patients.
- Understanding nonclassical risk factors is essential for managing cardiovascular health in CKD.
Abstract:
Cardiovascular complications are a major clinical problem in patients with chronic kidney disease and end-stage renal failure; cardiac death accounts for approximately 40-50% of all deaths in these patients. Death from cardiovascular causes is up to 20 times more common in uremic patients than in the general population with the risk being even higher than in patients with diabetes mellitus. A high rate of myocardial infarction and excessive cardiac mortality have repeatedly been documented in patients with kidney disease and renal failure. Not only is the prevalence of myocardial infarction high, but also the case fatality rate is significantly higher in uremic patients with and without diabetes, respectively, compared to nonuremic patients. This is of particular interest since the prevalence of coronary atheroma in uremic patients was shown to be approximately 30% by autopsy and coronary angiography studies. Thus, coronary factors, i.e. atherosclerosis, and non-coronary factors may play an important role in the genesis of cardiac complications in the renal patient. In addition, renal failure recently has also be identified as a predictor of mortality in different stages of peripheral vascular disease. In particular, marked differences in the pathogenesis, morphology and course of atherosclerosis and arteriosclerosis under the conditions of renal failure have been documented. Among others increased plaque formation and particularly higher proportion and intensity of vascular calcification have been found in clinical and autopsy studies. In addition to the so-called classical or traditional risk factors, an important role for nonclassical risk factors such as microinflammation, hyperphosphatemia and oxidative stress has been documented in patients with renal failure and is discussed in detail.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

